John Saharek
Corporate Officer/Principal chez HARROW, INC.
Fortune : 4 M $ au 31/05/2024
Profil
John P.
Saharek is currently the President & Chief Executive Officer at ImprimisRx LLC since 2012 and the Chief Commercial Officer at Harrow, Inc. since 2012.
Previously, he worked as the Vice President-Business Development at Surmodics, Inc. from 2006 to 2011.
He also held the position of Head-US Marketing & Strategy at Thrombogenics, Inc. Mr. Saharek completed his undergraduate degree at Central Connecticut State University and obtained an MBA from the University of Hartford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HARROW, INC.
0,71% | 16/04/2024 | 249 803 ( 0,71% ) | 4 M $ | 31/05/2024 |
Postes actifs de John Saharek
| Sociétés | Poste | Début |
|---|---|---|
| HARROW, INC. | Corporate Officer/Principal | 01/02/2015 |
| ImprimisRx LLC | Directeur Général | 02/01/2024 |
Anciens postes connus de John Saharek
| Sociétés | Poste | Fin |
|---|---|---|
| SURMODICS, INC. | Corporate Officer/Principal | 01/07/2011 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Sales & Marketing | - |
Formation de John Saharek
| Central Connecticut State University | Undergraduate Degree |
| University of Hartford | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SURMODICS, INC. | Health Technology |
| HARROW, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| ImprimisRx LLC | |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
